Another malignancy that is chemoresistant to therapy is chronic myeloid leukemia which is cancer of the bone marrow attributed to the constitutively active BCR-ABL oncogene. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.